Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds

PurposeHighly supersaturated aqueous solutions of poorly soluble compounds can undergo liquid-liquid phase separation (LLPS) when the concentration exceeds the “amorphous solubility”. This phenomenon has been widely observed during high throughput screening of new molecular entities as well as during the dissolution of amorphous solid dispersions. In this study, we have evaluated the use of environment-sensitive fluorescence probes to investigate the formation and properties of the non-crystalline drug-rich aggregates formed in aqueous solutions as a result of LLPS.MethodsSix different environment-sensitive fluorophores were employed to study LLPS in highly supersaturated solutions of several model compounds, all dihydropyridine derivatives.ResultsEach fluoroprobe exhibited a large hypsochromic shift with decreasing environment polarity. Upon drug aggregate formation, the probes partitioned into the drug-rich phase and exhibited changes in emission wavelength and intensity consistent with sensing a lower polarity environment. The LLPS onset concentrations determined using the fluorescence measurements were in good agreement with light scattering measurements as well as theoretically estimated amorphous solubility values.ConclusionsEnvironment-sensitive fluorescence probes are useful to help understand the phase behavior of highly supersaturated aqueous solutions, which in turn is important in the context of developing enabling formulations for poorly soluble compounds.

[1]  Lynne S Taylor,et al.  Dissolution and precipitation behavior of amorphous solid dispersions. , 2011, Journal of pharmaceutical sciences.

[2]  Michael J. Pikal,et al.  Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals , 2010, Pharmaceutical Research.

[3]  A. Nakamura,et al.  A methode for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: Dispersion ofΒ-carotene by polyvinylpyrrolidone , 1965 .

[4]  K. Edler,et al.  Insights into the Role of Polymer-Surfactant Complexes in Drug Solubilisation/Stabilisation During Drug Release from Solid Dispersions , 2012, Pharmaceutical Research.

[5]  Kiyohiko Sugano,et al.  High throughput solubility measurement with automated polarized light microscopy analysis. , 2006, Journal of pharmaceutical sciences.

[6]  Lynne S Taylor,et al.  Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs. , 2014, Journal of pharmaceutical sciences.

[7]  R. Wandruszka,et al.  Pyrene fluorescence in premicellar solutions: The effects of solvents and temperature , 1990 .

[8]  S. Veesler,et al.  Phase Transitions in Supersaturated Drug Solution , 2003 .

[9]  Geoff G. Z. Zhang,et al.  Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media. , 2014, Molecular pharmaceutics.

[10]  K. Abu-Salah,et al.  Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles. , 2012, Journal of pharmaceutical sciences.

[11]  James D. Litster,et al.  Quantitative analysis of the inhibitory effect of HPMC on felodipine crystallization kinetics using population balance modeling , 2013 .

[12]  Kristin E. D. Coan,et al.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. , 2008, Journal of the American Chemical Society.

[13]  E. Fasani,et al.  Photochemistry of 4-(2-Nitrophenyl)-1,4-Dihydropyridines. Evidence for Electron Transfer and Formation of an Intermediate† , 2006, Photochemistry and photobiology.

[14]  L. S. Taylor,et al.  Liquid–Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations , 2013 .

[15]  H. Mo,et al.  Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water-soluble drugs assessed using synchrotron radiation. , 2015, Journal of pharmaceutical sciences.

[16]  Lynne S. Taylor,et al.  Influence of Particle Size on the Ultraviolet Spectrum of Particulate-Containing Solutions: Implications for In-Situ Concentration Monitoring Using UV/Vis Fiber-Optic Probes , 2011, Pharmaceutical Research.

[17]  J. Hoffman Thermodynamic Driving Force in Nucleation and Growth Processes , 1958 .

[18]  J. Rekling,et al.  Development of a No-Wash Assay for Mitochondrial Membrane Potential Using the Styryl Dye DASPEI , 2010, Journal of biomolecular screening.

[19]  P. Wipf,et al.  Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers. , 2013, Molecular pharmaceutics.

[20]  N. Turro,et al.  Fluorescence probes for critical micelle concentration determination. , 1985, Langmuir : the ACS journal of surfaces and colloids.

[21]  Manuel García,et al.  Static and dynamic light scattering study on the association of some antidepressants in aqueous electrolyte solutions , 2000 .

[22]  D. T. Friesen,et al.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. , 2008, Molecular pharmaceutics.

[23]  C. Rinaldi,et al.  Effect of molecular weight, temperature, and additives on the moisture sorption properties of polyethylene glycol. , 2010, Journal of pharmaceutical sciences.

[24]  M. Brandl,et al.  In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation. , 2010, Journal of pharmaceutical and biomedical analysis.

[25]  Lynne S. Taylor,et al.  Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution , 2010, Pharmaceutical Research.

[26]  Anthony M Giannetti,et al.  Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. , 2008, Journal of medicinal chemistry.

[27]  E. Matayoshi,et al.  Solubility at the Molecular Level: Development of a Critical Aggregation Concentration (CAC) Assay for Estimating Compound Monomer Solubility , 2012, Pharmaceutical Research.

[28]  N. Turro,et al.  Fluorescence probe investigation of anionic polymer-cationic surfactant interactions , 1988 .

[29]  L. S. Taylor,et al.  Assessing the impact of polymers on the pH-induced precipitation behavior of poorly water soluble compounds using synchrotron wide angle X-ray scattering. , 2014, Journal of pharmaceutical sciences.

[30]  M. Brandl,et al.  What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? , 2014, Journal of pharmaceutical sciences.

[31]  M. Pikal,et al.  Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable? , 2011, Journal of pharmaceutical sciences.

[32]  Roland Roth,et al.  The role of cluster formation and metastable liquid - Liquid phase separation in protein crystallization , 2012 .

[33]  A. M. Carmona-Ribeiro,et al.  Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs. , 2003, Journal of colloid and interface science.

[34]  P. Pavez,et al.  Photophysics and Photochemical Studies of 1,4‐Dihydropyridine Derivatives , 2007, Photochemistry and photobiology.

[35]  Shan Ren,et al.  New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs , 2010, The Journal of pharmacy and pharmacology.

[36]  L. S. Taylor,et al.  Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments , 2013, Pharmaceutical Research.

[37]  Bernard Van Eerdenbrugh,et al.  pH-Induced Precipitation Behavior of Weakly Basic Compounds: Determination of Extent and Duration of Supersaturation Using Potentiometric Titration and Correlation to Solid State Properties , 2012, Pharmaceutical Research.

[38]  Benedetta Mennucci,et al.  What is solvatochromism? , 2010, The journal of physical chemistry. B.

[39]  Gert Fricker,et al.  The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility , 2012, International journal of nanomedicine.

[40]  T. Rades,et al.  Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. , 2010, Journal of pharmaceutical sciences.

[41]  Lynne S. Taylor,et al.  Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs , 2015, Pharmaceutical Research.

[42]  Bernard Van Eerdenbrugh,et al.  A classification system to assess the crystallization tendency of organic molecules from undercooled melts. , 2010, Journal of pharmaceutical sciences.

[43]  Ravi M Shanker,et al.  Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. , 2010, Journal of pharmaceutical sciences.